To meet patient needs, reliable and cost-effective manufacturing processes are crucial. Yet, the complexity of scaling viral vector processes to commercial levels and the absence of standardized ...

In the early days of genetic engineering, scientists predicted gene therapies that would treat, or even cure, inherited disease by inserting a healthy gene into a patient’s cells to replace a ...

David started his career in Manufacturing Operations in Downstream processing and validation of vaccine manufacturing processes. David received his undergraduate degree in Biomedical Sciences from the ...

the 2nd Viral Vector Process Development & Manufacturing Summit is your must-attend meeting in 2024. Secure your place and get your burning questions answered to enhance process intensification ...

Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.